Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic
- PMID: 35134624
- PMCID: PMC8808327
- DOI: 10.1016/j.virol.2022.01.011
Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic
Abstract
SARS-CoV-2, the seventh coronavirus known to infect humans, can cause severe life-threatening respiratory pathologies. To better understand SARS-CoV-2 evolution, genome-wide analyses have been made, including the general characterization of its codons usage profile. Here we present a bioinformatic analysis of the evolution of SARS-CoV-2 codon usage over time using complete genomes collected since December 2019. Our results show that SARS-CoV-2 codon usage pattern is antagonistic to, and it is getting farther away from that of the human host. Further, a selection of deoptimized codons over time, which was accompanied by a decrease in both the codon adaptation index and the effective number of codons, was observed. All together, these findings suggest that SARS-CoV-2 could be evolving, at least from the perspective of the synonymous codon usage, to become less pathogenic.
Keywords: Betacoronavirus; COVID-19; Codon usage bias; SARS-CoV-2.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures













Similar articles
-
Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.Virus Res. 2020 Oct 15;288:198113. doi: 10.1016/j.virusres.2020.198113. Epub 2020 Aug 7. Virus Res. 2020. PMID: 32771430 Free PMC article.
-
Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.J Med Virol. 2021 Sep;93(9):5630-5634. doi: 10.1002/jmv.27056. Epub 2021 May 24. J Med Virol. 2021. PMID: 33934387 Free PMC article.
-
Characterization of codon usage pattern in SARS-CoV-2.Virol J. 2020 Sep 14;17(1):138. doi: 10.1186/s12985-020-01395-x. Virol J. 2020. PMID: 32928234 Free PMC article.
-
Genotype and phenotype of COVID-19: Their roles in pathogenesis.J Microbiol Immunol Infect. 2021 Apr;54(2):159-163. doi: 10.1016/j.jmii.2020.03.022. Epub 2020 Mar 31. J Microbiol Immunol Infect. 2021. PMID: 32265180 Free PMC article. Review.
-
A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis.Mol Cell Biochem. 2021 Nov;476(11):3987-4002. doi: 10.1007/s11010-021-04217-y. Epub 2021 Jun 30. Mol Cell Biochem. 2021. PMID: 34195882 Free PMC article. Review.
Cited by
-
Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development.Adv Sci (Weinh). 2023 Aug;10(23):e2205445. doi: 10.1002/advs.202205445. Epub 2023 Jun 2. Adv Sci (Weinh). 2023. PMID: 37267926 Free PMC article.
-
Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies.Virol J. 2023 Feb 17;20(1):31. doi: 10.1186/s12985-023-01982-8. Virol J. 2023. PMID: 36812119 Free PMC article.
-
The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19.BMC Infect Dis. 2024 Mar 4;24(1):281. doi: 10.1186/s12879-024-09146-x. BMC Infect Dis. 2024. PMID: 38439047 Free PMC article.
-
Utilizing the codon adaptation index to evaluate the susceptibility to HIV-1 and SARS-CoV-2 related coronaviruses in possible target cells in humans.Front Cell Infect Microbiol. 2023 Jan 25;12:1085397. doi: 10.3389/fcimb.2022.1085397. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36760235 Free PMC article.
-
Attenuation and Degeneration of SARS-CoV-2 Despite Adaptive Evolution.Cureus. 2023 Jan 3;15(1):e33316. doi: 10.7759/cureus.33316. eCollection 2023 Jan. Cureus. 2023. PMID: 36741655 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous